Evaluation of microRNAs − 208 and 133a/b as differential biomarkers of acute cardiac and skeletal muscle toxicity in rats

Toxicology and Applied Pharmacology

Volumn 312, Issue , 2016, Pages 53-60

  Calvano, Jacqueline ^a   Achanzar, William ^a   Murphy, Bethanne ^a   DiPiero, Janet ^a   Hixson, Clifford ^a   Parrula, Cecilia ^a   Burr, Holly ^a   Mangipudy, Raja ^a   Tirmenstein, Mark ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Biomarker; Cardiotoxicity; miR 133a b; miR 208; miRNA; Skeletal myotoxicity

Indexed keywords

ALLYLAMINE; CARRIER PROTEINS AND BINDING PROTEINS; FATTY ACID BINDING PROTEIN 3; ISOPRENALINE; MICRORNA; MICRORNA 133A; MICRORNA 133B; MICRORNA 208; MITOXANTRONE; MYOSIN; MYOSIN LIGHT CHAIN 3; ORCIPRENALINE; PARACETAMOL; TROPONIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN133 MICRORNA, HUMAN; MIRN208 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD SAMPLING; CARDIOTOXICITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; GENE EXPRESSION; HEART; HEART INJURY; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; MALE; MITOCHONDRION; MORTALITY; NONHUMAN; RAT; SKELETAL MUSCLE; SKELETAL MUSCLE TOXICITY; TOXICITY; ANIMAL; BLOOD; DRUG EFFECTS; SPRAGUE DAWLEY RAT;

ACETAMINOPHEN; ALLYLAMINE; ANIMALS; BIOMARKERS; HEART; ISOPROTERENOL; MALE; METAPROTERENOL; MICRORNAS; MITOXANTRONE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84954285763     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.11.015     Document Type: Article

References (19)

1. Ambros, V., The functions of animal miRNAs. Nature 7006 (2004), 350–355.
2. Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
3. Biagini, R.E., Torasson, M.A., Lynch, D.W., Winston, G.W., Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite acrolein. Toxicology 62 (1990), 95–106.
4. Calvano, J., Rosini-Marthaler, L., Fletcher, A., Larkin, M., Tirmenstein, M., Mangipudy, R., Achanzar, W., Isoproterenol-induced cardiotoxicity and increases in serum miRNAs in rats. Toxicol. Sci., 109(53 (Suppl.)), 2014 (Abstract).
5. Cortez, M.S., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A.K., Calin, G.A., MicroRNAs in body fluids—the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8 (2011), 467–477.
6. Finsterer, J., Ohnsorge, P., Influence of mitochondrion-toxic agents on cardiovascular sytem. Regul. Toxicol. Pharmacol. 3 (2013), 434–445.
7. Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., Iwai, N., Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 11 (2009), 1944–1949.
8. Minami, K., Uehara, T., Morikawa, Y., Omura, K., Kanki, M., Horinouchi, A., Ono, A., Yamada, H., Ohno, Y., Urushidani, T., miRNA expression atlas in male rat. Nature, 1, 2014, 140005.
9. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B., Tewari, M., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 30 (2008), 10513–10518.
10. Nishimura, Y., Morikawa, Y., Kondo, C., Tomomura, Y., Fukushima, R., Torii, M., Uehara, T., Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies. J. Appl. Toxicol. 10 (2013), 1120–1130.
11. Nishimura, Y., Kondo, C., Morikawa, Y., Tomomura, Y., Torii, M., Yamate, J., Uehara, T., Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats. J. Appl. Toxicol. 35 (2015), 173–180.
12. O'Brien, P.J., Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 245:2008 (2008), 206–218.
13. Plasterk, R.H., Micro RNAs in animal development. Cell 124 (2006), 877–881.
14. Pritt, M.L., Hall, D.G., Recknor, J., Credile, K.M., Brown, D.D., Yumbie, N.P., Schultze, A.E., Watson, D.E., Fabp3 as a marker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers. Toxicol. Sci. 103 (2008), 382–396.
15. Reagan, W.J., Troponin as a biomarker of cardiac toxicity: past, present and future. Toxicol. Pathol. 38 (2010), 1134–1137.
16. Tonomura, Y., Mori, Y., Torii, M., Uehara, T., Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats. Toxicology 266 (2009), 48–54.
17. Tonomura, Y., Matsushima, S., Kashiwagi, E., Fujsawa, K., Takagi, S., Nishimura, Y., Fukushima, R., Torii, M., Matsubara, M., Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats. Toxicology 302 (2012), 179–189.
18. Wang, G.K., Zhu, J.Q., Zhang, J.T., Li, Q., L, I.Y., He, J., Qin, Y.W., Jing, Q., Circulating microRNA: a novel potential biomarker for early diagnoisis of acute myocradial infarction in humans. Eur. Heart J. 6 (2010), 659–666.
19. Yu, H., Lu, Y., Wang, Q., microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer. Curr. Drug Targets 15 (2014), 817–828.